Boston Scientific Valuation
| 0HOY Stock | 101.62 0.30 0.30% |
At this time, the firm appears to be undervalued. Boston Scientific Corp shows a prevailing Real Value of USD114.76 per share. The current price of the firm is USD101.62. Our model approximates the value of Boston Scientific Corp from analyzing the firm fundamentals such as Return On Equity of 0.0892, profit margin of 0.11 %, and Current Valuation of 158.95 B as well as examining its technical indicators and probability of bankruptcy.
Enterprise Value 159 B | Price Sales 8.8689 | Trailing PE 1.9196 |
Undervalued
Today
Please note that Boston Scientific's price fluctuation is very steady at this time. Calculation of the real value of Boston Scientific Corp is based on 3 months time horizon. Increasing Boston Scientific's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Boston stock is determined by what a typical buyer is willing to pay for full or partial control of Boston Scientific Corp. Since Boston Scientific is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Boston Stock. However, Boston Scientific's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 101.62 | Real 114.76 | Hype 101.88 | Naive 102.47 |
The intrinsic value of Boston Scientific's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Boston Scientific's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Boston Scientific Corp helps investors to forecast how Boston stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Boston Scientific more accurately as focusing exclusively on Boston Scientific's fundamentals will not take into account other important factors: Boston Scientific Cash |
|
Boston Scientific Total Value Analysis
Boston Scientific Corp is presently projected to have takeover price of 158.95 B with market capitalization of 104.15 B, debt of 9.57 B, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Boston Scientific fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
158.95 B | 104.15 B | 9.57 B |
Boston Scientific Investor Information
About 92.0% of the company shares are owned by institutions such as pension funds. The company had not issued any dividends in recent years. Based on the measurements of operating efficiency obtained from Boston Scientific's historical financial statements, Boston Scientific Corp is not in a good financial situation at this time. It has a very high probability of going through financial hardship in February.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Total Cash From Operating Activities | 1.5 B | 2.9 B |
|
| |||||
| Operating Income | 1.5 B | 2.7 B |
|
|
Boston Scientific Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Boston Scientific has an asset utilization ratio of 40.53 percent. This implies that the Company is making USD0.41 for each dollar of assets. An increasing asset utilization means that Boston Scientific Corp is more efficient with each dollar of assets it utilizes for everyday operations.Boston Scientific Ownership Allocation
Boston Scientific holds a total of 1.38 Billion outstanding shares. The majority of Boston Scientific Corp outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Boston Scientific Corp to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Boston Scientific. Please pay attention to any change in the institutional holdings of Boston Scientific Corp as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Boston Scientific Profitability Analysis
The company reported the revenue of 14.24 B. Net Income was 1.59 B with profit before overhead, payroll, taxes, and interest of 10.94 B.About Boston Scientific Valuation
The stock valuation mechanism determines Boston Scientific's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Boston Scientific Corp based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Boston Scientific. We calculate exposure to Boston Scientific's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Boston Scientific's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 11.3 B | 6.9 B |
Additional Tools for Boston Stock Analysis
When running Boston Scientific's price analysis, check to measure Boston Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Boston Scientific is operating at the current time. Most of Boston Scientific's value examination focuses on studying past and present price action to predict the probability of Boston Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Boston Scientific's price. Additionally, you may evaluate how the addition of Boston Scientific to your portfolios can decrease your overall portfolio volatility.